Literature DB >> 12070085

Effects of heterodimerization and proteolytic processing on Derrière and Nodal activity: implications for mesoderm induction in Xenopus.

Peter M Eimon1, Richard M Harland.   

Abstract

Derrière is a recently discovered member of the TGFbeta superfamily that can induce mesoderm in explant assays and is expressed at the right time and location to mediate mesoderm induction in response to VegT during Xenopus embryogenesis. We show that the ability of Derrière to induce dorsal or ventral mesoderm depends strictly on the location of expression and that a dominant-negative Derrière cleavage mutant completely blocks all mesoderm formation when ectopically expressed. This differs from the activity of similar Xnr2 cleavage mutant constructs, which are secreted and retain signaling activity. Additional analysis of mesoderm induction by Derrière and members of the Nodal family indicates that these molecules are involved in a mutual positive-feedback loop and antagonism of either one of the signals can reduce the other. Interaction between Derrière and members of the Nodal family is also shown to occur through the formation of heterodimeric ligands. Using an oocyte expression system we show direct interaction between the mature Derrière ligand and members of both the Nodal and BMP families. Taken together, these findings indicate that Derrière and Nodal proteins probably work cooperatively to induce mesoderm throughout the marginal zone during early Xenopus development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12070085     DOI: 10.1242/dev.129.13.3089

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  19 in total

1.  The competence of Xenopus blastomeres to produce neural and retinal progeny is repressed by two endo-mesoderm promoting pathways.

Authors:  Bo Yan; Sally A Moody
Journal:  Dev Biol       Date:  2007-02-07       Impact factor: 3.582

2.  The role of FGF signaling in the establishment and maintenance of mesodermal gene expression in Xenopus.

Authors:  Russell B Fletcher; Richard M Harland
Journal:  Dev Dyn       Date:  2008-05       Impact factor: 3.780

3.  HEB and E2A function as SMAD/FOXH1 cofactors.

Authors:  Se-Jin Yoon; Andrea E Wills; Edward Chuong; Rakhi Gupta; Julie C Baker
Journal:  Genes Dev       Date:  2011-08-01       Impact factor: 11.361

4.  A large bioactive BMP ligand with distinct signaling properties is produced by alternative proconvertase processing.

Authors:  Takuya Akiyama; Guillermo Marqués; Kristi A Wharton
Journal:  Sci Signal       Date:  2012-04-03       Impact factor: 8.192

Review 5.  Agonists and Antagonists of TGF-β Family Ligands.

Authors:  Chenbei Chang
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-08-01       Impact factor: 10.005

6.  Subtilisin-like proprotein convertase activity is necessary for left-right axis determination in Xenopus neurula embryos.

Authors:  Ryuji Toyoizumi; Shigeo Takeuchi; Kazue Mogi
Journal:  Dev Genes Evol       Date:  2006-07-05       Impact factor: 0.900

7.  An essential role for transcription before the MBT in Xenopus laevis.

Authors:  Jennifer Skirkanich; Guillaume Luxardi; Jing Yang; Laurent Kodjabachian; Peter S Klein
Journal:  Dev Biol       Date:  2011-06-29       Impact factor: 3.582

8.  Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7.

Authors:  Guoxiong Xu; Stefanie Bernaudo; Guodong Fu; Daniel Y Lee; Burton B Yang; Chun Peng
Journal:  Mol Biol Cell       Date:  2008-09-10       Impact factor: 4.138

9.  Cleavages within the prodomain direct intracellular trafficking and degradation of mature bone morphogenetic protein-4.

Authors:  Catherine Degnin; François Jean; Gary Thomas; Jan L Christian
Journal:  Mol Biol Cell       Date:  2004-09-08       Impact factor: 4.138

10.  Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto.

Authors:  Paul W Harms; Chenbei Chang
Journal:  Genes Dev       Date:  2003-10-16       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.